How Eliem Therapeutics Is Shaping the Future of Neurologic Drug Development
Explore Eliem Therapeutics— a clinical‑stage biotech on Nasdaq driving breakthrough treatments for neurological diseases and growing into a global healthcare leader.
3 minutes to read